Nestlé USA cites consumer complaints, including "one potential choking incident" for recalling products sold nationwide.
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...
New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback